Zevra Therapeutics Ownership | Who Owns Zevra Therapeutics?


OverviewForecastRevenueFinancialsChartTranscripts

Zevra Therapeutics Ownership Summary


Zevra Therapeutics is owned by 72.59% institutional investors, 0.78% insiders, and 26.63% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 7.37% of ZVRA shares.

ZVRA Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockZevra Therapeutics72.59%0.78%26.63%
SectorHealthcare Stocks 42.54%10.83%46.63%
IndustryBiotech Stocks 45.22%10.75%44.04%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock funding, inc. /de4.04M7.37%$38.39M
Woodline partners lp3.48M6.35%$33.06M
Vanguard group3.08M5.63%$29.32M
Adage capital partners gp2.23M4.06%$21.16M
Altium capital management lp1.85M3.87%$15.43M
Nantahala capital management1.97M3.60%$18.75M
Fmr1.63M2.98%$15.54M
State street1.43M2.61%$13.57M
Geode capital management1.30M2.37%$12.37M
Aigh capital management1.23M2.25%$11.72M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Stonepine capital management810.00K6.26%$7.70M
Altium capital management lp1.85M4.38%$15.43M
Aigh capital management1.23M3.30%$11.72M
Retirement planning co of new england600.77K2.30%$5.71M
Propel bio management231.87K2.21%$2.21M
Kingdon capital management650.00K0.77%$6.18M
Mystic asset management346.65K0.74%$3.30M
Nantahala capital management1.97M0.65%$18.75M
683 capital management975.00K0.48%$9.27M
Pharvision advisers66.73K0.36%$634.63K

Top Buyers

HolderShares% AssetsChange
Marshall wace, llp912.30K0.01%912.30K
Royce & associates lp691.24K0.07%691.24K
Caption management510.09K0.04%510.09K
Nantahala capital management1.97M0.65%500.00K
Tudor investment corp et al447.90K0.01%447.90K

Top Sellers

HolderShares% AssetsChange
Rubric capital management lp---1.96M
Adage capital partners gp2.23M0.03%-1.94M
Woodline partners lp3.48M0.16%-1.14M
Velan capital investment management lp---715.00K
Fmr1.63M0.00%-654.67K

New Positions

HolderShares% AssetsChangeValue
Marshall wace, llp912.30K0.01%912.30K$8.68M
Royce & associates lp691.24K0.07%691.24K$6.57M
Tudor investment corp et al447.90K0.01%447.90K$4.26M
Algert global418.55K0.07%418.55K$3.98M
Trexquant investment lp302.86K0.03%302.86K$2.88M

Sold Out

HolderChange
Thompson investment management-1.00
Capital performance advisors llp-40.00
Srs capital advisors-87.00
Ronald blue trust-121.00
Point72 (difc)-264.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 202516942.02%39,764,01312.97%721.76%10155.38%3737.04%
Jun 30, 20251256.84%36,154,6521.99%651.54%6815.25%28-3.45%
Mar 31, 20251162.65%35,432,6354.54%651.30%58-13.43%2970.59%
Dec 31, 202453-54.31%11,658,947-59.74%240.66%24-63.64%8-55.56%
Sep 30, 202411619.59%28,960,46980.52%604.13%6617.86%1820.00%

Recent Insider Transactions


DateNameRoleActivityValue
Oct 10, 2025McFarlane Neil F. President and CEOSell$210.91K
Sep 12, 2025FAVORITO TAMARA A-Buy$24.72K
Sep 12, 2025Shih Alvin-Buy$157.80K
Aug 19, 2025Bode John B-Buy$45.83K
Jun 26, 2025Thompson Rahsaan Chief Legal & ComplianceSell$221.00K

Insider Transactions Trends


DateBuySell
2025 Q4-1
2025 Q33-
2025 Q2-1
2025 Q125
2024 Q41-

ZVRA Ownership FAQ


Who Owns Zevra Therapeutics?

Zevra Therapeutics shareholders are primarily institutional investors at 72.59%, followed by 0.78% insiders and 26.63% retail investors. The average institutional ownership in Zevra Therapeutics's industry, Biotech Stocks , is 45.22%, which Zevra Therapeutics exceeds.

Who owns the most shares of Zevra Therapeutics?

Zevra Therapeutics’s largest shareholders are Blackrock funding, inc. /de (4.04M shares, 7.37%), Woodline partners lp (3.48M shares, 6.35%), and Vanguard group (3.08M shares, 5.63%). Together, they hold 19.34% of Zevra Therapeutics’s total shares outstanding.

Does Blackrock own Zevra Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Zevra Therapeutics.

Who is Zevra Therapeutics’s biggest shareholder by percentage of total assets invested?

Stonepine capital management is Zevra Therapeutics’s biggest shareholder by percentage of total assets invested, with 6.26% of its assets in 810K Zevra Therapeutics shares, valued at 7.7M$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools